News

• Awakn Announces Exclusive License Deal with the University of Exeter to Commercialise the 'Ketamine in the Reduction of Alcoholic Relapse' (KARE) Intervention Validated in a Phase II Clinical Trial
  03/02/2021 / 13:50 - Newsfile Corp
•  
• Vishay Intertechnology Launches Industry’s First SMD Ceramic Safety Capacitors With Y1 Rating of 500 VAC and 1500 VDC
  02/24/2021 / 17:00 - GlobeNewswire
•  
• AC Immune to Present New Data from Alpha-Synuclein and TDP-43 Programs at the AD/PD™ 2021 Virtual Conference
  02/24/2021 / 13:00 - GlobeNewswire
•  
• AC Immune to Highlight Promising Alzheimer’s Vaccine at the SVB Leerink 10th Annual Global Healthcare Conference
  02/17/2021 / 13:00 - GlobeNewswire
•  
• AC Immune’s Alzheimer’s Vaccine Generates Potent Anti-pTau Antibody Response in a Phase 1b/2a Study
  02/11/2021 / 13:00 - GlobeNewswire
•  
• AC Immune Initiates Clinical Study of First-in-class Diagnostic for Parkinson’s Disease
  02/08/2021 / 13:00 - GlobeNewswire
•  
• Electriq Power Introduces AC-Coupled PowerPod 2 LFP-Based Residential Battery Storage System
  02/04/2021 / 15:00 - GlobeNewswire
•  
• AC Immune Reports Progress for Therapeutic Programs Targeting the NLRP3 Inflammasome Pathway
  01/29/2021 / 13:00 - GlobeNewswire
•  
• First Solar Signs Definitive Agreement to Sell US Development Platform to Leeward
  01/25/2021 / 14:00 - GlobeNewswire
•  
• Aptos Solar Technology and NEP Join Forces to Provide High-Performance AC Solutions
  01/13/2021 / 12:46 - GlobeNewswire
•  
• Preliminary results from Carbalive and Dialive trials signal potential for new therapies to treat decompensated cirrhosis and reverse liver failure 
  01/07/2021 / 08:01 - GlobeNewswire
•  
• Power Control Reference Design Enables a Secondary Side Microcontroller to Control Primary Power
  01/06/2021 / 14:09 - GlobeNewswire
•  
• AzurRx BioPharma Announces Exclusive Worldwide License Agreement with First Wave Bio for Use of Proprietary Niclosamide Formulations to Treat Immune Checkpoint Inhibitor-Associated Colitis and COVID-19 Gastrointestinal Infections
  01/04/2021 / 13:00 - GlobeNewswire
•  
• Lexicon Pharmaceuticals Enters Data Collaboration With AC Bioscience
  12/16/2020 / 22:05 - GlobeNewswire
•  
• AC Immune Receives Competitive Target ALS Foundation Grant to Accelerate the Development of Proprietary Phosphorylated TDP-43 Immuno-assay
  12/15/2020 / 14:00 - GlobeNewswire